‘2 Strong’ system in entecavir market, led by Dong-A and Bukwang
In the market of entecavir(product name: Baraclude), one of the last year’s largest issues in the patent expiration field, Dong-A ST and Bukwang Pharm have formed a 2-stong competition.
For the 3rd position, Hanmi Pharm and Samil Pharm have started to get prepared as increasing their products’ ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
